Dotefonium

Dotefonium

SCHEMBL29387913

CN(CC[N+]1(C)CCCC1)C(=O)C(O)(c1ccccc1)c1cccs1

nearest known ligand 0.41

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CHRM3 P20309 14/20 0.41
CHRM2 P08172 13/20 0.41
CHRM1 P11229 13/20 0.41
CHRM4 P08173 2/20 0.41
CHRM5 P08912 2/20 0.41
ALDH1A1 P00352 3/20 0.40
POLB P06746 1/20 0.40
LMNA P02545 2/20 0.39
KMT2A Q03164 2/20 0.39
MEN1 O00255 1/20 0.39
GAA P10253 1/20 0.39
MAPT P10636 1/20 0.39
HTT P42858 1/20 0.39
RECQL P46063 1/20 0.39
NPSR1 Q6W5P4 1/20 0.39
RGS12 O14924 1/20 0.39
CYP2D6 P10635 2/20 0.38
HRH1 P35367 1/20 0.38
KCNH2 Q12809 1/20 0.38
HPGD P15428 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Dotefonium SCHEMBL2733352 0.99 CHRM3 (0.41) CHRM3CHRM2CHRM1CHRM4CHRM5
SCHEMBL14408517 0.68 CHRM3 (0.48) CHRM3CHRM2CHRM1ALDH1A1POLB
SCHEMBL4620168 0.68 CHRM3 (0.41) CHRM3CHRM2CHRM1CHRM4ALDH1A1
SCHEMBL5964331 0.68 CHRM3 (0.50) CHRM3CHRM2CHRM1ALDH1A1POLB
SCHEMBL73656 0.68 CHRM3 (0.50) CHRM3CHRM2CHRM1ALDH1A1POLB
SCHEMBL11284831 0.68 CHRM3 (0.50) CHRM3CHRM2CHRM1ALDH1A1POLB
SCHEMBL74291 0.67 CHRM3 (0.49) CHRM3CHRM2CHRM1ALDH1A1POLB
Etipirium SCHEMBL29388403 0.66 CHRM2 (0.69) CHRM3CHRM2CHRM1CHRM4CHRM5
Etipirium SCHEMBL916033 0.65 CHRM2 (0.67) CHRM3CHRM2CHRM1CHRM4CHRM5
SCHEMBL28905886 0.65 CHRM3 (0.54) CHRM3CHRM2CHRM1ALDH1A1POLB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20220047505-A1 Controlled Absorption Water-Soluble Pharmaceutically Active Organic Compound Formulation for Once-Daily Administration STI PHARMA, LLC (US) 2022-02-17 US disclosed